No Source Code == No Patent
How we know you "have' the invention
Stay updated with breaking news from Xcath Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Supreme Court's (re)consideration of the enablement requirement expected in its decision later this year in Amgen v. Sanofi may be the most closely watched patent case since AMP v....
Inventions with numerical ranges are valuable across different technologies. Obtaining claims with numerical ranges provide competitive advantages to patent owners. Frequently, a...
Can new material be added to a provisional patent application in subsequent stages? The USPTO for one has a 'conservation of matter' clause - no new…
Cerus Endovascular Announces the First Ever Robotic Assist Intracranial Implant of its Contour Intrasaccular Device Groundbreaking Aneurysm Procedure Completed in 28 Minutes News provided by Share this article Share this article FREMONT, Calif. and OXFORD, United Kingdom, Dec. 17, 2020 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced the first ever robotically assisted intracranial implant of its Contour intrasaccular device. The groundbreaking procedure was completed at the King Edward Memorial Hospital, Mumbai, by renowned...